BridgeBio Pharma (BBIO) Intangibles (2021 - 2026)
BridgeBio Pharma (BBIO) reported Intangibles of $26.64 million for Q2 2026, down 9.7% from $29.51 million a year earlier and down 2.6% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma posted Intangibles of $28.08 million, up 17.3% from FY2024.
- Intangibles has a four-year compound annual growth rate of -11.1% (FY2021 to FY2025).
- By year, Intangibles came in at $23.93 million in FY2024 (-9.1%), $26.32 million in FY2023 (-8.3%), $28.71 million in FY2022 (-36.1%) and $44.93 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Intangibles since Q4 2024.
- Year over year, Intangibles gained in four of the last eight quarters, with growth averaging 3.9%.
- The high point for year-over-year Intangibles in five years was Q2 2025 (growth of 17.5%); the low point was Q3 2022 (a decline of 36.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $27.36 million (Q1 2026), $28.08 million (Q4 2025) and $28.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 412.80 Mn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 26.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.64 Mn |
| Mar 31, 2026 | 27.36 Mn |
| Dec 31, 2025 | 28.08 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | 29.51 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 23.93 Mn |
| Sep 30, 2024 | 24.53 Mn |
| Jun 30, 2024 | 25.12 Mn |
| Mar 31, 2024 | 25.72 Mn |
| Dec 31, 2023 | 26.32 Mn |
| Sep 30, 2023 | 26.92 Mn |
| Jun 30, 2023 | 27.52 Mn |
| Mar 31, 2023 | 28.11 Mn |
| Dec 31, 2022 | 28.71 Mn |
| Sep 30, 2022 | 29.31 Mn |
| Jun 30, 2022 | 29.91 Mn |
| Mar 31, 2022 | 30.48 Mn |
| Dec 31, 2021 | 44.93 Mn |
| Sep 30, 2021 | 46.20 Mn |
API Access
BridgeBio Pharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();